Navigation Links
Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
Date:11/9/2009

iveness/being easily distracted, running around or climbing excessively, arguing with adults, losing temper, and interrupting or intruding on others. Significant improvements in mean day total scores were seen on both scales: based on the CPRS-R, parents reported significant improvement across a full day (as measured at 6 pm, 8 pm, and 6 am the next morning); based on the CTRS-R, which was used only in the first pivotal trial, teachers reported significant improvement throughout the school day (as measured at 10 am and

2 pm).

Safety was also evaluated during these pivotal trials and safety data showed that adverse events reported by participants using INTUNIV were generally mild to moderate in severity. Treatment-related adverse events greater than 10 percent included somnolence (32 percent), headache (26 percent), fatigue (18 percent), upper abdominal pain (14 percent), and sedation (13 percent). Sedation-related, treatment emergent adverse events were among the most common and were usually transient and mild to moderate in severity. Small to modest changes in blood pressure, pulse rate, and ECG parameters were observed.

Additional information about INTUNIV and Full Prescribing Information are available at http://www.intuniv.com.

Important Safety Information

INTUNIV is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17. Efficacy was established in two controlled clinical trials (8 and 9 weeks in duration). The physician electing to use INTUNIV for extended periods should periodically reevaluate its long-term usefulness for the individual patient.

INTUNIV should not be used in patients with a history of hypersensitivity to guanfacine or any of its inactive ingredients or by patients taking other products containing guanfacine.

Hypotension, bradycardia, an
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
2. New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners ADHD Rating Scale
3. Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
4. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
5. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
6. Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
7. New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting
8. New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation
9. ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
10. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
11. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015   BioClinica®, Inc ... provider, today announced that it has acquired a ... ® , Inc. (Medici).  The acquisition includes affiliates ... LLC.  Medici also provides a lost-to-follow-up patient locate ... globally.  Together with Medici, BioClinica will ...
(Date:7/6/2015)... BEDFORD, Mass. , July 6, 2015 ... the Company plans to release its financial results for ... 29, 2015, after the market closes.  In conjunction with ... day at 4:30 p.m. Eastern Time. Interested ... (in the United States ) or ...
(Date:7/6/2015)... FARMINGTON, Conn. , July 6, ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... Series E warrants to purchase 21,917,808 shares of ... purchase 2,191,781 shares of its common stock.  Certain ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
... 29, 2012 STAAR Surgical Company (NASDAQ: ... implantable lenses for the eye, today announced that it ... the Company,s recent financial results and current business developments ... Company One-on-One Investor Conference will be held on Thursday, ...
... May 29, 2012  Abaxis, Inc. (NasdaqGS: ABAX), a medical ... that Clint Severson, chairman and chief executive officer , ... on Tuesday, June 5, 2012 at 9:00 a.m. ET. ... in New York City. About AbaxisAbaxis ...
Cached Medicine Technology:STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences 2
(Date:7/6/2015)... ... July 06, 2015 , ... ... for radiology services and ADVOCATE is leading the transition. ADVOCATE, the only 100% ... with their Top 10 Tips for ICD-10. The ten tips are timely and ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... redesigned site allows newly-diagnosed cancer patients, caregivers and medical professionals to chat with ... survived the same cancer. , “Receiving a cancer diagnosis is often the most ...
(Date:7/6/2015)... ... July 06, 2015 , ... With ... has once again teamed up with Family Emergency Shelter Coalition (FESCO) and announced ... self-sufficiency. FESCO was created especially to provide emergency services and support for homeless ...
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community ... with Livonia Save Our Youth and announced a new charity campaign to raise funds ... to alcohol and drug abuse. Livonia Save Our Youth is a coalition created especially ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering ... Kybella is a non-surgical method to dissolve fat cells and is the ... severe fat deposits under the chin, commonly known as a double chin. Dr. Green ...
Breaking Medicine News(10 mins):Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2
... 8, 2008 Optimal Readings,Services Group, Inc., a ... radiology groups, announced today that Rita Edwards has,been ... the recent acquisition of two radiology groups (National,Radiology ... provides,radiology services for more than 115 hospitals," said ...
... lung cancer (SCLC) patients treated with high-dose chemotherapy did ... standard doses, according to a randomized controlled trial published ... National Cancer Institute . , SCLC accounts for nearly ... States. Although many patients with SCLC initially respond to ...
... ports and shipping regions may be markedly worse than ... industrial and shipping pollution is exacerbated when it combines ... paper published in this weeks advance online edition of ... included University of Calgary chemistry professor Hans Osthoff report ...
... DUBLIN, Ohio, April 8, 2008 Cardinal Health,Inc. (NYSE: ... that improve,the safety and productivity of health care, plans to ... to the opening of trading,on the New York Stock Exchange., ... for May 1 at,8:30 a.m. EDT to discuss results of ...
... Survival time rose with combo therapy for advanced disease, ... By combining a special type of chemotherapy (TACE) with ... the survival of people with advanced liver cancer by ... either treatment alone. , "Our study demonstrates that combination ...
... drugs by women during their childbearing years and there ... alone or in combination with other drugs, may have ... evidence that THC, the main psychoactive component of marijuana, ... intrauterine growth retardation and that infants exposed to marijuana ...
Cached Medicine News:Health News:Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations 2Health News:High-intensity chemotherapy does not improve survival in small cell lung cancer 2Health News:Sea salt worsens coastal air pollution: study 2Health News:Cardinal Health to Announce Third-Quarter Results on May 1 2Health News:Cardinal Health to Announce Third-Quarter Results on May 1 3Health News:Two Liver Cancer Treatments Better Than One 2Health News:Two Liver Cancer Treatments Better Than One 3Health News:Marijuana increases alcohol toxicity in young rats 2
... ACMI™ offers five classes of ... vaporization, cutting loops, knife, roller bar ... are the only electrodes specifically integrated ... surgical tissue removal with minimal bleeding, ...
... ACMITM MRO™-2004 and MRO™-2005 Rigid ... and large working throughput capacity with ... large operating channels with small size ... irrigation ports for easy positioning during ...
... Rotating Continuous Flow Resectoscopes enhance ease of ... the working element and telescope to the ... result no rotating components in the ... rotating flow ports, simplifying procedures. The new ...
... Used for temporary internal drainage from the ... material is engineered for ease of placement ... monofilament tether designed for repositioning and ease ... of hydrophilic polymer that when activated, attracts ...
Medicine Products: